Two temperature-sensitive (ts) mutants (ts 21 and ts 24), which could complement each other, were isolated from cell culture-passaged murine cytomegalovirus (CC-MCMV). Characterization in vivo revealed that ts 21 lacked pathogenicity for suckling mice, neurovirulence for weanling mice and productive chronic infection in the salivary gland, whereas ts 24 was positive only for the first two parameters; both mutants retained immunogenicity comparable to that of the wild-type CC-MCMV. The immunogenicity of ts 21 and ts 24 was assessed by mortality of the immunized mice after challenge with virulent, salivary gland-passaged MCMV (SG-MCMV) and by replication of the challenge virus in the immunized hosts. The protective immunity conferred by ts 21 was maintained over a period of 3 months without production of infectious viruses in the salivary gland.
BelsheR. B.,
RichardsonL. S.,
LondonW. T.,
SlyD. L.,
CamargoE.,
PrevarD. A.,
ChanockR. M.1978; Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates. II. Genetic analysis of virus recovered during infection. Journal of Medical Virology 3:101–110
CheungK.-S.,
LangD. J.1977; Detection of latent cytomegalovirus in murine salivary and prostate explant cultures and cells. Infection and Immunity 15:568–575
ChongK. T.,
GouldJ. J.,
MimsC. A.1981; Neutralization of different strains of murine cytomegalovirus (MCMV) – effect of in vitro passage. Archives of Virology 69:95–104
HoM.,
AshmanR. B.1979; Development in vitro of cytotoxic lymphocytes against murine cytomegalovirus. Australian Journal of Biological and Medical Science 57:425–428
HowardR. J.,
BalfourH. H.1977; Prevention of morbidity and mortality of wild murine cytomegalovirus by vaccination with attenuated cytomegalovirus. Proceedings of the Society for Experimental Biology and Medicine 156:365–368
HudsonI. B.,
MisraV.,
MosmannT. R.1976b; Cytomegalovirus infectivity: analysis of the phenomenon of centrifugal enhancement of infectivity. Virology 72:235–243
IharaS.,
HiraiK.,
WatanabeY.1978; Temperature-sensitive mutants of human cytomegalovirus: isolation and partial characterization of DNA-minus mutants. Virology 84:218–221
JordanM. C.,
ShanleyJ. D.,
StevensJ. G.1977; Immunosuppression reactivates and disseminates latent murine cytomegalovirus. Journal of General Virology 31:419–423
MinamishimaY.,
EizuruY.1974; Protective immunity in cytomegalovirus infection of mice. Proceedings of the First Intersectional Congress of I AMS 4:50–54
MinamishimaY.,
EizuruY.,
YoshidaA.,
FukunishiR.1978a; Murine model for immunoprophylaxis of cytomegalovirus infection. I. Efficacy of immunization. Microbiology and Immunology 22:693–700
MinamishimaY.,
ShishimeY.,
EizuruY.1978b; Neurovirulence of murine cytomegalovirus. Abstrac ts, Fourth International Congress for Virology (The Hague, The Netherlands)
OhsakiM.,
ChibaS.,
NakaoT.1970; Studies on the murine cytomegalovirus infection; viral growth and histopathological changes in the central nervous system. Virus 2:11–14 (in Japanese with English summary)
OldingL. B.,
JensenF. C.,
OldstoneM. B. A.1975; Pathogenesis of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction. Journal oj Experimental Medicine 141:561–572
PlotkinS. A.,
FarquharJ.,
HornbergerE.1976; Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus. Journal of Infectious Diseases 134:470–475
TrousdaleM. D.,
PaqueR. E.,
NealonT.,
GaunttC. J.1979; Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model. Infection and Immunity 23:486–495